Elicio Therapeutics Inc (ELTX)
7.88
+0.37
(+4.93%)
USD |
NASDAQ |
May 31, 16:00
7.90
+0.02
(+0.25%)
After-Hours: 20:00
Elicio Therapeutics Cash and Short Term Investments (Quarterly): 11.85M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.85M |
| December 31, 2023 | 12.89M |
| September 30, 2023 | 14.84M |
| Date | Value |
|---|---|
| June 30, 2023 | 21.68M |
| December 31, 2022 | 6.156M |
| March 31, 2021 | 13.93M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
6.156M
Minimum
Dec 2022
21.68M
Maximum
Jun 2023
13.56M
Average
13.41M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Immuneering Corp | 71.28M |
| Outlook Therapeutics Inc | 47.23M |
| Amylyx Pharmaceuticals Inc | 373.29M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |